We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
08 May 2019
The appeal surrounding Remicade arose in the context of a 15 February 2017 decision of the minister of health and social services to:
On 16 January 2019 the Quebec Court of Appeal found the minister's decision to delist Remicade from Quebec's List of Medications (the Quebec equivalent to a formulary) to be invalid and ordered the minister to reinstate the drug on the list.(1) In allowing the appeal, the court did not comment on the merits of delisting Remicade, instead holding that:
The court concluded that the minister had violated procedural fairness and should have given Janssen formal notice and an opportunity to respond before making the change. On 11 February 2019 the minister published an amendment to the list, reinstating full coverage of Remicade.
For further information on this topic please contact Tierney GB Deluzio at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (firstname.lastname@example.org). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.